Analgesics is the second largest category within OTC in Greece in value terms. The low retail price of Depon, together with the wide use of brands that do not have an OTC status for pain relief, such as Mesulid or Ponstan, are the main factors behind the low per capita spending on OTC analgesics in Greece.
Euromonitor International's Analgesics in Greece report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
ANALGESICS IN GREECE
Euromonitor International
February 2019
LIST OF CONTENTS AND TABLES
Headlines
Prospects
Growth Hindered by the Prevalence of Non-otc Brands
Specialised Products Could Give A Boost in Value
Demand for Quick Relief Drives Growth for Max Strength Products
Competitive Landscape
Depon Leads Analgesics Sales
Gsk Consumer Healthcare Gains Share, Driven by Panadol's Good Performance
Bayer Expands Its Aspirin Portfolio
Category Data
Table 1 Sales of Analgesics by Category: Value 2013-2018
Table 2 Sales of Analgesics by Category: % Value Growth 2013-2018
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2013-2018
Table 4 NBO Company Shares of Analgesics: % Value 2014-2018
Table 5 LBN Brand Shares of Analgesics: % Value 2015-2018
Table 6 Forecast Sales of Analgesics by Category: Value 2018-2023
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2018-2023
Executive Summary
Consumer Health Reshaped by Legislative Changes
Sales Increase Amid Price Hikes and An Increase in Self-medication
Depon Remains the Undisputed Leading Brand
Despite the Liberation of OTC Products' Distribution, Chemists/pharmacies Continues To Hold the Lion's Share
Forecasts Are Optimistic for Consumer Health
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018
Market Data
Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Distribution of Consumer Health by Format: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format and Category: % Value 2018
Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Summary: Get latest Market Research Reports on Analgesics. Industry analysis & Market Report on Analgesics is a syndicated market report, published as Analgesics in Greece. It is complete Research Study and Industry Analysis of Analgesics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.